Heidelberg pharma: magenta therapeutics to further develop antibody targeted amanitin conjugates

Heidelberg pharma ag: partner magenta therapeutics exercises option to further develop antibody targeted amanitin conjugates targeted to cd45.heidelberg pharma receives an undisclosed milestone payment in return.

DNTH Ratings Summary

DNTH Quant Ranking